Literature DB >> 26291276

Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.

Deepika S Darbari1, Johnson P Hampson2, Eric Ichesco2, Nadja Kadom3, Gilbert Vezina4, Iordanis Evangelou5, Daniel J Clauw2, James G Taylor Vi6, Richard E Harris2.   

Abstract

UNLABELLED: Sickle cell disease (SCD) is a hemoglobinopathy that affects more than 100,000 individuals in the United States. The disease is characterized by the presence of sickle hemoglobin and recurrent episodes of pain. Some individuals with SCD experience frequent hospitalizations and a high burden of pain. The role of central mechanisms in SCD pain has not been explored. Twenty-five adolescents and young adults with SCD underwent functional magnetic resonance imaging. Participants were stratified into groups with high pain or low pain based on the number of hospitalizations for pain in the preceding 12 months. Resting state functional connectivity was analyzed using seed-based and dual regression independent component analysis. Intrinsic brain connectivity was compared between the high pain and low pain groups, and association with fetal hemoglobin, a known modifier of SCD, was explored. Patients in the high pain group displayed an excess of pronociceptive connectivity such as between anterior cingulate and default mode network structures, such as the precuneus, whereas patients in the low pain group showed more connectivity to antinociceptive structures such as the perigenual and subgenual cingulate. Although a similar proportion of patients in both groups reported that they were on hydroxyurea, the fetal hemoglobin levels were significantly higher in the low pain group and were associated with greater connectivity to antinociceptive structures. These findings support the role of central mechanisms in SCD pain. Intrinsic brain connectivity should be explored as a complementary and objective outcome measure in SCD pain research. PERSPECTIVE: Altered connectivity patterns associated with high pain experience in patients with sickle cell disease suggest a possible role of central mechanisms in sickle cell pain. Resting state brain connectivity studies should be explored as an effective methodology to investigate pain in SCD.
Copyright © 2015 American Pain Society. All rights reserved.

Entities:  

Keywords:  Sickle cell disease; brain network connectivity; functional neuroimaging; pain

Mesh:

Substances:

Year:  2015        PMID: 26291276      PMCID: PMC4986827          DOI: 10.1016/j.jpain.2015.07.005

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  44 in total

1.  Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study.

Authors:  Jian Kong; Pei-chi Tu; Carolyn Zyloney; Tung-ping Su
Journal:  Behav Brain Res       Date:  2010-03-27       Impact factor: 3.332

2.  Placebo effects on human mu-opioid activity during pain.

Authors:  Tor D Wager; David J Scott; Jon-Kar Zubieta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

3.  Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie
Journal:  J Pain Symptom Manage       Date:  2014-03-15       Impact factor: 3.612

4.  Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Authors:  Carlton Dampier; Beth Ely; Darcy Brodecki; Camille Coleman; Leela Aertker; Jocelyn Andrel Sendecki; Benjamin Leiby; Karen Kesler; Terry Hyslop; Marie Stuart
Journal:  Pediatr Blood Cancer       Date:  2013-09-24       Impact factor: 3.167

5.  Modulation of pain processing in hyperalgesia by cognitive demand.

Authors:  Katja Wiech; Ben Seymour; Raffael Kalisch; Klaas Enno Stephan; Martin Koltzenburg; Jon Driver; Raymond J Dolan
Journal:  Neuroimage       Date:  2005-08-01       Impact factor: 6.556

6.  Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; F B Barton; R D Moore; M L Terrin; M H Steinberg; G J Dover; S K Ballas; R P McMahon; O Castro; E P Orringer
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

7.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05

8.  Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients.

Authors:  Richard E Harris; Vitaly Napadow; John P Huggins; Lynne Pauer; Jieun Kim; Johnson Hampson; Pia C Sundgren; Bradley Foerster; Myria Petrou; Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

Review 9.  Thinking beyond sickling to better understand pain in sickle cell disease.

Authors:  Deepika S Darbari; Samir K Ballas; Daniel J Clauw
Journal:  Eur J Haematol       Date:  2014-05-16       Impact factor: 2.997

Review 10.  Neurobiological mechanisms of placebo responses.

Authors:  Jon-Kar Zubieta; Christian S Stohler
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

View more
  33 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

2.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

Review 3.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 4.  New insights into sickle cell disease: mechanisms and investigational therapies.

Authors:  Gregory J Kato
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

Review 5.  Mast cell-neural interactions contribute to pain and itch.

Authors:  Kalpna Gupta; Ilkka T Harvima
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 6.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

Review 7.  Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.

Authors:  Varun Sagi; Donovan A Argueta; Stacy Kiven; Kalpna Gupta
Journal:  Complement Ther Med       Date:  2020-05-11       Impact factor: 2.446

Review 8.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

9.  Neuromodulation Management of Chronic Neuropathic Pain in The Central Nervous system.

Authors:  Kai Yu; Xiaodan Niu; Bin He
Journal:  Adv Funct Mater       Date:  2020-06-10       Impact factor: 18.808

Review 10.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.